CD274 and gastric cancer: Moreover, patients with unresectable or metastatic GC with MSI-H and EBV positivity also experience significant clinical benefit from the ICI treatment, because it upregulates the PD-L1 expression (Marabelle et al. 2020; Chao et al. 2021; Rodriquenz, et al. 2020).